• Issues related to coverage and reimbursement of pharmaceutical products. Issues related to screening and treatment of hepatitis C, oncology and rheumatoid arthritis.
• Coverage of pharmaceuticals, cost-sharing and other access issues.
• Issues related to National Institutes of Health (NIH), Centers for Disease Control (CDC), and other funding.

Duration: February 1, 2013 to December 31, 2017

General Issues: Medicare/Medicaid, Health Issues, Medical/Disease Research/Clinical Labs, Pharmacy

Spending: about $830,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2013: U.S. Senate, House of Representatives, Centers For Medicare and Medicaid Services (CMS), Centers For Medicare and Medicaid Services (CMS)